Presentation Predictors and Outcomes of Staged vs One-Time Revascularization in Multivessel CAD November 20, 2018
Presentation AHA 2018 Ticagrelor vs Aspirin in Patients undergoing Coronary-Artery Bypass Grafting Presenter: Heribert Schunkert November 14, 2018
Presentation FFR and Quality-of-Life Improvement After PCI in Patients With Stable CAD October 03, 2018
Presentation TCT Abstracts Posters 2018 Tackling bifurcation PCI in complicated STEMI: switching from single to two-stent strategy as bail-out Presenter: Fathima Aaysha Cader September 25, 2018
Presentation TCT Abstracts Posters 2018 Gender Differences in Presentation, Management and Outcomes Among Patients with Acute Coronary Syndrome in Dhaka, Bangladesh Presenter: Fathima Aaysha Cader September 25, 2018
Presentation TCT 2018 EVOLVE SHORT-DAPT: Three-Month Outcomes on Dual Antiplatelet Therapy in a High Bleeding Risk Population Treated With a Bioresorbable Polymer-Based Drug-Eluting Stent Presenter: Dominick J. Angiolillo, Neal S. Kleiman, Ajay J. Kirtane September 24, 2018
Presentation TCT 2018 GLOBAL LEADERS: A Randomized Trial of Ticagrelor Monotherapy After PCI - Patient-Oriented Clinical Outcomes and Net Adverse Cardiovascular Events Presenter: Dominick J. Angiolillo, Neal S. Kleiman, Patrick W. Serruys September 24, 2018
Presentation TCT 2018 The Asian Anti-Platelet Therapy Paradox: Genetic Factors, Dosing, Bleeding, and Stent Thrombosis Risk Presenter: Dominick J. Angiolillo, Elmir Omerovic, Duk-Woo Park September 23, 2018
Presentation TCT 2018 De-Escalation of DAPT After DES Placement: Is There a Role for Personalized Treatment? Presenter: Dominick J. Angiolillo, Elmir Omerovic, Dániel Aradi September 23, 2018
Presentation TCT 2018 GLOBAL LEADERS in Perspective: Perspectives on Ticagrelor Monotherapy Presenter: Dominick J. Angiolillo, Elmir Omerovic, Patrick W. Serruys September 23, 2018
Presentation TCT 2018 Managing Aspirin Allergy Before DES Placement Presenter: Dominick J. Angiolillo, Elmir Omerovic, John A. Bittl September 23, 2018
Presentation TCT 2018 Consensus: Considerations In The High Bleeding Risk Patient Requiring PCI And Oral Anticoagulant Therapy Presenter: George D. Dangas, Giuseppe Tarantini, Roxana Mehran September 23, 2018
Presentation TCT 2018 Case #2 Introduction: A Patient With Chronic CAD At High Bleeding Risk Requiring PCI Presenter: George D. Dangas, Giuseppe Tarantini, Steven R. Bailey, Giovanni Esposito, Juan F. Granada, Roxana Mehran, Francesco Saia September 23, 2018
Presentation TCT 2018 Consensus: PCI Considerations In The High Bleeding Risk Patient With Chronic CAD Presenter: George D. Dangas, Giuseppe Tarantini September 23, 2018
Presentation TCT 2018 Utility of Cangrelor During PCI and Bridging Who Benefits Most? Presenter: John A. Bittl, C. Michael Gibson, Deepak L. Bhatt September 23, 2018
Presentation TCT 2018 How Strong are the Pharmacodynamic Data and Clinical Evidence for Crushed Ticagrelor and Prasugrel? Presenter: John A. Bittl, C. Michael Gibson, Dimitrios Alexopoulos September 23, 2018
Presentation TCT 2018 The Case for Bivalirudin With Radial (and Femoral) Access Presenter: John A. Bittl, C. Michael Gibson, Carey D. Kimmelstiel September 23, 2018
Presentation TCT 2018 Case #1 Introduction: A High Bleeding Risk Patient With Afib And ACS Requiring PCI And Oral Anticoagulant Therapy Presenter: George D. Dangas, Giuseppe Tarantini, Steven R. Bailey, Giovanni Esposito, Juan F. Granada, Roxana Mehran, Francesco Saia September 23, 2018
Presentation TCT 2018 The Latest Antithrombotic Data: MATRIX at 1 Year Presenter: John A. Bittl, C. Michael Gibson, Stephan Windecker September 23, 2018
Presentation TCT 2018 Switching Dual Antiplatelet Therapy After PCI: Who, When, Why, and How? Presenter: John A. Bittl, C. Michael Gibson, Matthew J. Price September 23, 2018